Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer's disease neurodegeneration

Frontiers in Aging Neuroscience

Volumn 7, Issue JUL, 2015, Pages

  Casoli, Tiziana ^a   Spazzafumo, Liana ^a   Di Stefano, Giuseppina ^a   Conti, Fiorenzo ^a,b  

^a INRCA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Aging; Allele; Alzheimer's disease; Heteroplasmy; MitoChip; mtDNA; Mutation

Indexed keywords

CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ARTICLE; CALCIUM HOMEOSTASIS; DNA DAMAGE; DNA MODIFICATION; GENE MUTATION; HETEROPLASMY; HUMAN; MEMBRANE FUSION; MITOCHONDRIAL GENE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION SWELLING; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; POSITRON EMISSION TOMOGRAPHY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84938598693     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00142     Document Type: Article

References (59)

1. Area-Gomez, E., Del Carmen Lara Castillo, M., Tambini, M. D., Guardia-Laguarta, C., de Groof, A. J., Madra, M., et al. (2012). Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J. 31, 4106-4123. doi: 10.1038/emboj.2012.202
2. Avital, G., Buchshtav, M., Zhidkov, I., Tuval Feder, J., Dadon, S., Rubin, E., et al. (2012). Mitochondrial DNA heteroplasmy in diabetes and normal adults: role of acquired and inherited mutational patterns in twins. Hum. Mol. Genet. 21, 4214-4224. doi: 10.1093/hmg/dds245
3. Bloom, G. S. (2014). Amyloid-ß and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 71, 505-508. doi: 10.1001/jamaneurol.2013.5847
4. Brody, D. L., Magnoni, S., Schwetye, K. E., Spinner, M. L., Esparza, T. J., Stocchetti, N., et al. (2008). Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321, 1221-1224. doi: 10.1126/science.1161591
5. Casoli, T., Di Stefano, G., Spazzafumo, L., Balietti, M., Giorgetti, B., Giuli, C., et al. (2014). Contribution of non-reference alleles in mtDNA of Alzheimer's disease patients. Ann. Clin. Transl. Neurol. 1, 284-289. doi: 10.1002/acn3.42
6. Cha, M. Y., Kim, D. K., and Mook-Jung, I. (2015). The role of mitochondrial DNA mutation on neurodegenerative diseases. Exp. Mol. Med. 47:e150. doi: 10.1038/emm.2014.122
7. Coon, K. D., Valla, J., Szelinger, S., Schneider, L. E., Niedzielko, T. L., Brown, K. M., et al. (2006). Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing. Mitochondrion 6, 194-210. doi: 10.1016/j.mito.2006.07.002
8. Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., McKee, A. C., Beal, M. F., et al. (1994). Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23, 471-476. doi: 10.1006/geno.1994.1525
9. Coskun, P. E., Beal, M. F., and Wallace, D. C. (2004). Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc. Natl. Acad. Sci. U S A 101, 10726-10731. doi: 10.1073/pnas.0403649101
10. Coskun, P., Wyrembak, J., Schriner, S. E., Chen, H. W., Marciniack, C., LaFerla, F., et al. (2012). A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta 1820, 553-564. doi: 10.1016/j.bbagen.2011.08.008
11. Coto, E., Gómez, J., Alonso, B., Corao, A. I., Díaz, M., Menéndez, M., et al. (2011). Late-onset Alzheimer's disease is associated with mitochondrial DNA 7028C/haplogroup H and D310 poly-C tract heteroplasmy. Neurogenetics 12, 345-346. doi: 10.1007/s10048-011-0295-4
12. Fernández, M., Gobartt, A. L., Balañá, M., and COOPERA Study Group. (2010). Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment. BMC Neurol. 10:87. doi: 10.1186/1471-2377-10-87
13. Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., et al. (2006). Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch. Neurol. 63, 1402-1408. doi: 10.1001/archneur.63.10.1402
14. Frey, C., Bonert, A., Kratzsch, T., Rexroth, G., Rösch, W., Müller-Spahn, F., et al. (2006). Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer's disease. J. Neural Transm. 11, 1753-1761. doi: 10.1007/s00702-006-0481-y
15. Gabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P., and Yankner, B. A. (1994). Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269, 13623-13628.
16. Galindo, M. F., Ikuta, I., Zhu, X., Casadesus, G., and Jordán, J. (2010). Mitochondrial biology in Alzheimer's disease pathogenesis. J. Neurochem. 114, 933-945. doi: 10.1111/j.1471-4159.2010.06814.x
17. Gasparini, L., Racchi, M., Benussi, L., Curti, D., Binetti, G., Bianchetti, A., et al. (1997). Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells. Neurosci. Lett. 231, 113-117. doi: 10.1016/s0304-3940(97)00536-3
18. Gibson, G. E., Sheu, K. F., and Blass, J. P. (1998). Abnormalities of mitochondrial enzymes in Alzheimer disease. J. Neural Transm. 105, 855-870. doi: 10.1007/s007020050099
19. Guo, Y., Li, C. I., Sheng, Q., Winther, J. F., Cai, Q., Boice, J. D., et al. (2013). Very low-level heteroplasmy mtDNA variations are inherited in humans. J. Genet. Genomics 40, 607-615. doi: 10.1016/j.jgg.2013.10.003
20. Herrup, K. (2015). The case for rejecting the amyloid cascade hypothesis. Nat. Neurosci. 18, 794-799. doi: 10.1038/nn.4017
21. Honea, R. A., Vidoni, E. D., Swerdlow, R. H., and Burns, J. M. (2012). Alzheimer's disease neuroimaging initiative. maternal family history is associated with Alzheimer's disease biomarkers. J. Alzheimers Dis. 31, 659-668. doi: 10.3233/JAD-2012-120676
22. Hou, T., Wang, X., Ma, Q., and Cheng, H. (2014). Mitochondrial flashes: new insights into mitochondrial ROS signaling and beyond. J. Physiol. 592, 3703-3713. doi: 10.1113/jphysiol.2014.275735
23. Hudson, G., Sims, R., Harold, D., Chapman, J., Hollingworth, P., Gerrish, A., et al. (2012). GERAD1 Consortium. No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology 78, 1038-1042. doi: 10.1212/WNL.0b013e31824e8f1d
24. Inestrosa, N. C., Alarcón, R., Arriagada, J., Donoso, A., Alvarez, J., and Campos, E. O. (1994). Blood markers in Alzheimer disease: subnormal acetylcholinesterase and butyrylcholinesterase in lymphocytes and erythrocytes. J. Neurol. Sci. 122, 1-5. doi: 10.1016/0022-510x(94)90044-2
25. Kennedy, S. R., Salk, J. J., Schmitt, M. W., and Loeb, L. A. (2013). Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damage. PLoS Genet. 9:e1003794. doi: 10.1371/journal.pgen.1003794
26. Khan, S. M., Cassarino, D. S., Abramova, N. N., Keeney, P. M., Borland, M. K., Trimmer, P. A., et al. (2000). Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann. Neurol. 48, 148-155. doi: 10.1002/1531-8249(200008)48:2<148::aid-ana3>3.3.co;2-z
27. Krishnan, K. J., Greaves, L. C., Reeve, A. K., and Turnbull, D. (2007). The ageing mitochondrial genome. Nucleic Acids Res. 35, 7399-7405. doi: 10.1093/nar/gkm635
28. Kukreja, L., Kujoth, G. C., Prolla, T. A., Van Leuven, F., and Vassar, R. (2014). Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease. Mol. Neurodegener. 9:16. doi: 10.1186/1750-1326-9-16
29. Lagouge, M., and Larsson, N. G. (2013). The role of mitochondrial DNA mutations and free radicals in disease and ageing. J. Intern. Med. 273, 529-543. doi: 10.1111/joim.12055
30. Larsson, N. G. (2010). Somatic mitochondrial DNA mutations in mammalian aging. Annu. Rev. Biochem. 79, 683-706. doi: 10.1146/annurev-biochem-060408-093701
31. Leuner, K., Schulz, K., Schütt, T., Pantel, J., Prvulovic, D., Rhein, V., et al. (2012). Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes. Mol. Neurobiol. 46, 194-204. doi: 10.1007/s12035-012-8300-y
32. Lin, M. T., Simon, D. K., Ahn, C. H., Kim, L. M., and Beal, M. F. (2002). High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 11, 133-145. doi: 10.1093/hmg/11.2.133
33. Lloret, A., Badía, M. C., Mora, N. J., Pallardó, F. V., Alonso, M. D., and Viña, J. (2009). Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. J. Alzheimers Dis. 17, 143-149. doi: 10.3233/JAD-2009-1033
34. Maurer, I., Zierz, S., and Möller, H. J. (2000). A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol. Aging 21, 455-462. doi: 10.1016/s0197-4580(00)00112-3
35. Mecocci, P., Beal, M. F., Cecchetti, R., Polidori, M. C., Cherubini, A., Chionne, F., et al. (1997). Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Mol. Chem. Neuropathol. 31, 53-64. doi: 10.1007/bf02815160
36. Michikawa, Y., Mazzucchelli, F., Bresolin, N., Scarlato, G., and Attardi, G. (1999). Aging-dependent large accumulation of point mtDNA mutations in the human mtDNA control region for replication. Science 286, 774-779. doi: 10.1126/science.286.5440.774
37. Miller, J. A., Oldham, M. C., and Geschwind, D. H. (2008). A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J. Neurosci. 28, 1410-1420. doi: 10.1523/JNEUROSCI.4098-07.2008
38. Moreira, P. I., Honda, K., Liu, Q., Santos, M. S., Oliveira, C. R., Aliev, G., et al. (2005). Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. Curr. Alzheimer Res. 2, 403-408. doi: 10.2174/156720505774330537
39. Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H., and Burns, J. M. (2014). Is Alzheimer's disease a systemic disease?. Biochim. Biophys. Acta 1842, 1340-1349. doi: 10.1016/j.bbadis.2014.04.012
40. Mosconi, L., de Leon, M., Murray, J., E, L., Lu, J., Javier, E., et al. (2011). Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. J. Alzheimers Dis. 27, 483-490. doi: 10.3233/JAD-2011-110866
41. Musiek, E. S., and Holtzman, D. M. (2015). Three dimensions of the amyloid hypothesis: time, space and 'wingmen'. Nat. Neurosci. 18, 800-806. doi: 10.1038/nn.4018
42. Parker, W. D. Jr., Mahr, N. J., Filley, C. M., Parks, J. K., Hughes, D., Young, D. A., et al. (1994). Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44, 1086-1090. doi: 10.1212/wnl.44.6.1086
43. Perl, D. P. (2010). Neuropathology of Alzheimer's disease. Mt. Sinai J. Med. 77, 32-42. doi: 10.1002/msj.20157
44. Peterson, C., Gibson, G. E., and Blass, J. P. (1985). Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease. N. Engl. J. Med. 312, 1063-1065. doi: 10.1056/nejm198504183121618
45. Ridge, P. G., Koop, A., Maxwell, T. J., Bailey, M. H., Swerdlow, R. H., Kauwe, J. S., et al. (2013). Mitochondrial haplotypes associated with biomarkers for Alzheimer's disease. PLoS One 8:e74158. doi: 10.1371/journal.pone.0074158
46. Ross, J. M., Stewart, J. B., Hagström, E., Brené, S., Mourier, A., Coppotelli, G., et al. (2013). Germline mitochondrial DNA mutations aggravate ageing and can impair brain development. Nature 501, 412-415. doi: 10.1038/nature12474
47. Santos, R. X., Correia, S. C., Zhu, X., Smith, M. A., Moreira, P. I., Castellani, R. J., et al. (2013). Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease. Antioxid. Redox Signal. 18, 2444-2457. doi: 10.1089/ars.2012.5039
48. Schon, E. A., DiMauro, S., and Hirano, M. (2012). Human mitochondrial DNA: roles of inherited and somatic mutations. Nat. Rev. Genet. 13, 878-890. doi: 10.1038/nrg3275
49. Selfridge, J. E., E, L., Lu, J., and Swerdlow, R. H. (2013). Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiol. Dis. 51, 3-12. doi: 10.1016/j.nbd.2011.12.057
50. Sheehan, J. P., Swerdlow, R. H., Miller, S. W., Davis, R. E., Parks, J. K., Parker, W. D., et al. (1997). Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J. Neurosci. 17, 4612-4622.
51. Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., et al. (1991). Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. U S A 88, 10540-10543. doi: 10.1073/pnas.88.23.10540
52. Supnet, C., and Bezprozvanny, I. (2010). Neuronal calcium signaling, mitochondrial dysfunction and Alzheimer's disease. J. Alzheimers Dis. 20, S487-S498. doi: 10.3233/JAD-2010-100306
53. Swerdlow, R. H., Burns, J. M., and Khan, S. M. (2014). The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim. Biophys. Acta 1842, 1219-1231. doi: 10.1016/j.bbadis.2013.09.010
54. Tacconi, S., Perri, R., Balestrieri, E., Grelli, S., Bernardini, S., Annichiarico, R., et al. (2004). Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer's disease. Exp. Neurol. 1, 254-262. doi: 10.1016/j.expneurol.2004.07.009
55. Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., et al. (2004). Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429, 417-423. doi: 10.1038/nature02517
56. Wang, S., Song, J., Tan, M., Albers, K. M., and Jia, J. (2012). Mitochondrial fission proteins in peripheral blood lymphocytes are potential biomarkers for Alzheimer's disease. Eur. J. Neurol. 19, 1015-1022. doi: 10.1111/j.1468-1331.2012.03670.x
57. Wang, X., Su, B., Lee, H. G., Li, X., Perry, G., Smith, M. A., et al. (2009). Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci. 29, 9090-9103. doi: 10.1523/JNEUROSCI.1357-09.2009
58. Ward, W. F., Qi, W., Van Remmen, H., Zackert, W. E., Roberts, J. L. IInd, and Richardson, A. (2005). Effects of age and caloric restriction on lipid peroxidation: measurement of oxidative stress by F2-isoprostane levels. J. Gerontol. A Biol. Sci. Med. Sci. 60, 845-847. doi: 10.1093/gerona/60.7.847
59. Xiang, Y., Xu, G., and Weigel-Van Aken, K. A. (2010). Lactic acid induces aberrant amyloid precursor protein processing by promoting its interaction with endoplasmic reticulum chaperone proteins. PLoS One 5:e13820. doi: 10.1371/journal.pone.0013820